Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Typically, when a brokerage firm fails, the Securities Investor Protection Corporation (SIPC) arranges the transfer of the failed brokerage's accounts to a different securities brokerage firm. https://www.uscourts.gov/services-forms/bankruptcy/bankruptcy-basics/securities-investor-protection-act-sipa#:~:text=Typically%2C%20when%20a%20brokerage%20firm,a%20different%20securities%20brokerage%20firm.
I could be mistaken, but I also recall flipper making the same point quite awhile ago about the CHM meeting not being relevant in the midst of a rolling review. Just giving credit where credits due. And thanks to you hoff for all your contributions.
Spoofing is one thing, but illegal shorting is another. The latter shifts the supply curve to the right and lowers the equilibrium share price starting point. I believe Posner and CM would still argue that there will have been a latent adverse effect on market capitalization even after a huge influx of equity funds, at least in the short-term.
Maybe trades from yesterday that hadn't been settled?
Hey aek, have you seen the TV series Goliath with Billy Bob Thornton? If not, it's worth a look if you are into that sort of thing. He's plays an unorthodox yet skilled attorney who's extremely effective when it comes to negotiating settlements. Laura Posner and Cohen Milstein will have a lot of leverage when it's their time to talk about settling. Of course, it'll be LP's decision on whether or not to accept any offers. Honestly, I have no idea what that number is, but my gut tells me that there will be a settlement. CM got a $1 billion on the Wells Fargo case, but their net worth is a lot more than Citadel's. That being said, considering all the evidence, what's a stake, and the fact that there are several other defendants, $1 billion sounds like a good starting point to me.
Harvard leads the pack with $50 billion+ in endowments. I agree with you that KG’s donation is more about politics than finances. Politics can be tricky however, and these types of institutions have been known to eat their young when money is involved. I think he and the others will settle for substantial amounts with the SEC and DOJ taking no further action.
Backatchya
Sky, pithy is good, but so is consistently providing a mountain of evidence supporting DCVax-L’s highly likely eventual approval. Much appreciated.
A little media attention never hurts.
8-14-2023, Top Penny Stocks Worth Keeping an Eye On: PRSNF/ PRSN.V, NWBO, AABB, CYDY
Northwest Biotherapeutics (OTC: NWBO) is a biotech company that is involved in the development of customized immunotherapy products. The products are meant to treat cancer with better effectiveness than existing treatments in North America and Europe. The products do not contain the sort of toxicities that are associated with treatments like chemotherapy.
Currently, the company is involved in the development of DCVax-customized immune therapies meant for treating solid cancer tumors. On March 20, the company made a joint announcement with the United Kingdom-based contract development and manufacturing organization (CDMO) leader Advent BioServices Inc.
The announcement referred to the fact that it had been issued an MIA license by the Medicines and Healthcare Products Regulatory Agency (MHRA). Thanks to the license, the company would be able to commercially manufacture cell therapy-related products at its GMP facility located in Sawston, the United Kingdom.
https://www.marketscreener.com/quote/stock/PERSONAS-SOCIAL-INCORPORA-49477091/news/Top-Penny-Stocks-Worth-Keeping-an-Eye-On-PRSNF-PRSN-V-NWBO-AABB-CYDY-44606131/
liehub :)
You may be right, but I think it was the Olmecs, not the Egyptians.
In a thread earlier today, I think it was determined that the 10-Q would be due on the 14th.
good one
I've got 80 on Ignore, but I admire and appreciate all those that don't ignore them and refute the comments of the shorts and FUDsters. I do read all the replies to those I ignore. It makes me too angry to read their lies, so I just ignore them and only read the fair and truthful posts.
On Level 2 today CDEL had a bid for 100,000 shares at 50 cents for a long time. I wonder if they are still spoofing. I hope NWBO is still tracking this.
Duplicate
I haven’t been notified by TDA yet regarding when my account will be transferred to Schwab. However, my understanding is that all the account transfers will be completed before 2024.
If Schwab didn’t used to allow OTC trades, I’m certain they do now. They acquired TDAmeritrade whose clients own OTC stocks. My TDA account hasn’t been transferred to Schwab yet, but they will at least have to enable former TDA clients to sell their NWBO shares. Just checked: Schwab’s website states that they charge $6.95 per OTC trade.
Hi StockFollower, I agree that up to this point in time, like you, I cannot find an example of the Biden administration doing anything to assist NWBO. But my comment was just positing that they might do something to push NWBO over the finish line leading into the 2024 election. BTW, I'm neither a Republican nor a Democrat; I'm an independent.
FDA approval of DCVax-L serendipitously leading into the November 2024 presidential election would be perfect timing for the Moonshot Program and Biden campaign.
In the interview, Ted Nesi that a Part 2/follow-up segment will be aired today at 6:00 p.m. as well.
Well then you have failed to take your first little baby step.
Not long ago, the bear argument was that the DCVax-L clinical trial will fail. Now their argument is that longs will have to wait a long time until it’s approved. After approvals, they will be whining about revenue levels. Eventually, they’ll disappear and move on to the next biotech startup and attempt to ruin it. Baby steps.
I don’t think we know when the stakeholder made the statement. 18-24 months from the diagnosis in August 2022 would indicate approval starting around the Feb 2024, MA acceptance around Nov 2023, and MA submission around Sep 2023.
mike00h, Problem solved. I went to settings and selected the "shown" option regarding replies to ignored posters. Thank you and GL.
Thx Dr Bala. Unfortunately, your suggestion didn’t work. Weird.
Moderators, this board isn’t functioning properly. I follow (I confirmed they are not on Ignore.) both SkyLimit2022 and eagle8 (active longs), and their posts this morning of 614561 and 614562, respectively, are not showing up on my feeds. I found their posts through reading threads. I may not be receiving posts from other longs for all I know. I find this highly suspicious. I wonder if anyone else is having this problem.
Doesn’t a RS require a vote?
Just having some Sunday morning fun here. The Hebrew word Beth hesda, or Bethesda, means “house of mercy”, and the generic name for DCVax-L is Murcidencel. Bethesda was a pool in Jerusalem reputed to have healing powers, and NWBO’s corporate office is in Bethesda, MD. Are these mere coincidences or mysterious harbingers of what’s to come? BTW, it’s been awhile since I said this, so I’ll say it again. Many thanks to all the posters who continue to share their DD with the rest of us. You all have convinced me that MHRA approval is right around the corner, and that Linda “Powers” has everything under control. Interestingly, “Linda is a feminine name of Spanish origin, meaning "pretty." It may also have German roots, stemming from the word "lind," which means "tender," or as a derivative of the linden tree. Symbolically, the linden tree has many positive associations, including love, prosperity, and healing.” :)
And if they have prioritized the MHRA modules, then we should be close to receiving the submission PR soon. Furthermore, the subsequent submission and acceptance PRs from the other RAs on the heels of the first one will hopefully support the share price until the MHRA approves. Hang in there folks.
I’m with you. I have so many people on ignore that I only see about half the posts. It’s obviously bullish that the amount of negative posts increase the closer we get to approval in the UK.
I meant disregard my post. I misread the CHM schedule.
Disregard.
Wrong, but let’s the lawyers battle it out. I think NWBO will win its lawsuit against those you still seem to be defending. Nevertheless, heavy trading is being reported in the first two hours of trading today.
It’s Friday. It could be that some margin account holders got paid today and aren’t wasting any time buying. Or, it could be just another rinse and repeat cycle from the criminals. Either way, we’ll likely see at least $3.00 this year with MAA from MHRA/UK.
This may have been posted already, but Advent continues to grow. Senior QA Officer, Supplier Management and Audit Advent Bioservices Sawston, England, United Kingdom. https://www.linkedin.com/jobs/view/3640534553
I read that the OTC market is open from 9:30 a.m. to 2:00 p.m. on Monday, July 3, 2023.
Duplicate
Dr. Linda Liau will be at the Congress of Neurological Surgeons 2023 Annual Meeting representing NWBO on Sept 9 - "Special Symposium 01: TNT: Transforming Neurosurgery through Technology: The Innovation Symposium" from 9:45 - 10:45 a.m. She’s not listed in the participant column, but her photo is included in the list of participants at the bottom of the page. https://www.cns.org/annualmeeting/program/all-sessions?search=&type=&date=&track=